ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Pediatric Precision Oncology: Parent and Adolescent Experiences | Hospital for Sick Children / Anita Villani, MD | Psychosocial Launch Grant | 2017 | Ontario |
Pediatric Sarcoma, Rhabdomyosarcoma, and Mechanisms of Origin | University of Texas Southwestern Medical Center / Rene Galindo | 'A' Award Grants | 2010 | Texas |
Perinatal Hormonal Biomarkers and Risk of Testicular Germ Cell Tumors | University of California Berkeley / Catherine Metayer, MD, PhD | Epidemiology Grants | 2014 | California |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma | Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) | Innovation Grants | 2015 | Virginia |
Pharmacogenomics of childhood AML susceptibility and treatment response. | Children’s Hospital of Philadelphia / Richard Aplenc | Innovation Grants | 2009 | Pennsylvania |
Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML | Boston Children’s Hospital / Alan Cantor, MD, PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | Massachusetts |
Phase I and II Clinical Research Program Infrastructure Award | University of Minnesota / Brenda Weigel, MD, MSc | Phase I/II Infrastructure Grants | 2011 | Minnesota |
Phase I and II Clinical Research Program Infrastructure Award | University of Minnesota / Brenda Weigel, MD & Emily Greengard MD | Phase I/II Infrastructure Grants | 2015 | Minnesota |
Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML | Children’s Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD | Reach Grants | 2017 | Wisconsin |
Phase I Trial of Indoximod in Combination with Temozolomide-based Therapy for Children with Progressive Primary Brain Tumors | Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, M.D., Ph.D. | Bio-Therapeutic Impact Award | 2014 | Georgia |